Home > Healthcare > Biotechnology > Biotechnology R&D > DNA Synthesis Market

DNA Synthesis Market Share

Report ID: GMI6000
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

DNA Synthesis Market Share

The market is characterized by a diverse array of companies offering a range of synthesis services and technologies. Key players in this market such as Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript Biotech Corporation, Integrated DNA Technologies, and Quintara Biosciences are dominating the market with their comprehensive service offerings, advanced technologies, and global presence. Additionally, startups like Synbio Technologies and Twist Bioscience are disrupting the market with novel synthesis platforms and rapid DNA assembly techniques. Partnerships and collaborations between industry players and academic institutions are common, fostering innovation and driving the development of cutting-edge solutions. Factors such as technological advancements, regulatory landscape, and strategic alliances continue to shape the competitive dynamics of the market.

DNA Synthesis Market Companies

Prominent players operating in the DNA synthesis industry include:

BIOMATIK
Bioneer Corporation
Eton Bioscience, Inc.
Eurofins Scientific
GenScript Biotech Corporation
IBA Lifesciences GmbH
Integrated DNA Technologies, Inc.
Kaneka Eurogentec S.A.
LGC Biosearch Technologies
OriGene Technologies, Inc.
ProMab Biotechnologies, Inc.
ProteoGenix
Quintara Biosciences
Synbio Technologies
Thermo Fisher Scientific Inc.
Twist Bioscience Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The DNA synthesis market was valued at USD 4 billion in 2023 and is projected to witness a 18.9% CAGR between 2024 to 2032, attributed to the advancements in synthetic biology and gene editing technologies.

Oligonucleotide synthesis service segment held 58% share of DNA synthesis in 2023 and will grow rapidly through 2032, due to its crucial role in various applications, including genetic testing, molecular diagnostics, synthetic biology, and gene editing.

North America DNA synthesis market held a revenue share of 36.5% in 2023 and is anticipated to record 18.4% CAGR through 2032, owing to the region

BIOMATIK, Bioneer Corporation, Eton Bioscience, Inc, Eurofins Scientific, GenScript Biotech Corporation, IBA Lifesciences GmbH, Integrated DNA Technologies, Inc. among others.